| Phase 2/3 | 1 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT06566755 | Cadonilimab (AK104) Combined With Chemotherapy and Bevacizumab as First-line Treatment… | Colorectal Cancer | Recruiting | 2024-08-22 |
| Phase 2/3 | ||||
| NCT05426486 | A Study of ARX788 Combined With Pyrotinib Maleate Versus TCBHP (Trastuzumab Plus… | HER2-positive Breast Cancer | Active, Not Recruiting | 2024-10-30 |
| Not applicable | ||||
| NCT07512648 | Efficacy and Safety of Sanyong Jiedu Granules in Treating Lumps-Type Non-Lactational… | Plasmacytic Mastitis | Not Yet Recruiting | 2026-04-06 |
| NCT06881550 | Real-world Study on Shenbailing Granules for Improving Qi and Blood Deficiency in… | Breast Cancer | Enrolling by Invitation | 2025-03-18 |
Breast Cancer (2) · Colorectal Cancer (1) · HER2-Positive Cancer (1)